Olema Pharmaceuticals annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
Olema Pharmaceuticals Depreciation & Amortization Growth & History (OLMA)
Olema Pharmaceuticals's depreciation and amortization was $490,000 for fiscal 2025.
View full Olema Pharmaceuticals company overviewOlema Pharmaceuticals annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $490,000 | $97,000 | +24.68% |
| 2024 | 2024-12-31 | $393,000 | $16,000 | +4.24% |
| 2023 | 2023-12-31 | $377,000 | $20,000 | +5.60% |
| 2022 | 2022-12-31 | $357,000 | $194,000 | +119.02% |
| 2021 | 2021-12-31 | $163,000 | $152,000 | +1381.82% |
| 2020 | 2020-12-31 | $11,000 | $2,000 | +22.22% |
| 2019 | 2019-12-31 | $9,000 | — | — |
Olema Pharmaceuticals quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $102,000 | −$30,000 | −22.73% |
| Q1 2026 | 2026-03-31 | $119,000 | −$9,000 | −7.03% |
| Q4 2025 | 2025-12-31 | $187,000 | — | — |
| Q3 2025 | 2025-09-30 | $43,000 | −$52,000 | −54.74% |
| Q2 2025 | 2025-06-30 | $132,000 | $38,000 | +40.43% |
| Q1 2025 | 2025-03-31 | $128,000 | $40,000 | +45.45% |
| Q3 2024 | 2024-09-30 | $95,000 | $5,000 | +5.56% |
| Q2 2024 | 2024-06-30 | $94,000 | −$5,000 | −5.05% |
| Q1 2024 | 2024-03-31 | $88,000 | −$12,000 | −12.00% |
| Q3 2023 | 2023-09-30 | $90,000 | −$1,000 | −1.10% |
| Q2 2023 | 2023-06-30 | $99,000 | $14,000 | +16.47% |
| Q1 2023 | 2023-03-31 | $100,000 | $16,000 | +19.05% |
| Q3 2022 | 2022-09-30 | $91,000 | $41,000 | +82.00% |
| Q2 2022 | 2022-06-30 | $85,000 | $54,000 | +174.19% |
| Q1 2022 | 2022-03-31 | $84,000 | $75,000 | +833.33% |
| Q3 2021 | 2021-09-30 | $50,000 | $48,000 | +2400.00% |
| Q2 2021 | 2021-06-30 | $31,000 | $29,000 | +1450.00% |
| Q1 2021 | 2021-03-31 | $9,000 | $6,000 | +200.00% |
| Q3 2020 | 2020-09-30 | $2,000 | — | — |
| Q2 2020 | 2020-06-30 | $2,000 | — | — |
| Q1 2020 | 2020-03-31 | $3,000 | — | — |
Olema Pharmaceuticals depreciation and amortization trends
Over the last five fiscal years, Olema Pharmaceuticals's depreciation and amortization increased from $11,000 to $490,000, a change of $479,000. The latest reported quarter, Q2 2026, shows $102,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Olema Pharmaceuticals source filings ↗